Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype

International Journal of Cancer

Volumn 97, Issue 1, 2002, Pages 7-14

  Foss, Brynjar ^a   Ulvestad, Elling ^b   Hervig, Tor ^b   Bruserud, Bystein ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cell lines; EGFRvIII; Electron microscopy; Invasion; SCLC; Transfection

Indexed keywords

DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; GENE DISRUPTION; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; ULTRASTRUCTURE; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; CARCINOMA, SMALL CELL; CELL COMMUNICATION; COLLAGEN; DNA PRIMERS; DOXYCYCLINE; DRUG COMBINATIONS; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; LAMININ; LUNG NEOPLASMS; MICROSCOPY, ELECTRON; MUTATION; NEOPLASM INVASIVENESS; PROTEOGLYCANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036132083     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1572     Document Type: Article

References (57)

1. Role of epidermal growth factor in carcinogenesis
2. Hormonal carcinogenesis in breast cancer: Cellular and molecular studies of malignant progression
3. Multistep progression from an oestrogen-dependent growth towards an autonomous growth in breast carcinogenesis
4. The type 1 (EGFR-related) family of growth factor receptors and their ligands
5. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family
6. Regulation of Caco-2 cell proliferation by basolateral membrane epidermal growth factor receptors
7. Growth modulation of mouse keratinocytes by transforming growth factors
8. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer cell lines that exhibit domain selective EGF receptor mitogenesis
9. Epidermal-growth factor receptors in human bladder cancer: Comparison of invasive and superficial tumours
10. Epidermal growth factor in non-small cell lung cancer
11. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma
12. Immunohistologic detection of epidermal growth factor receptor in human esophageal squamous cell carcinoma
13. In vitro invasion of small cell lung cancer cell lines correlates to the expression of the epidermal growth factor receptor
14. Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells
15. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas
16. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails
17. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas
18. Structural alterations of the epidermal growth factor receptor gene in human gliomas
19. A deletion within the ligand binding domain is responsible for activation of epidermal growth factor gene in human brain tumors
20. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors
21. Transformational and altered signal transduction by a naturally occurring mutant EGF receptor
22. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis
23. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
24. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
25. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
26. Enhanced tumorigenic behaviour of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras- Shc-Grb2 pathway
27. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer
28. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer
29. Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor
30. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
31. Expression of the epidermal growth factor receptor in human small cell lung cancer cell lines
32. Immunoelectron microscopy of the receptor for urokinase plasminogen activator and cathepsin D in the human breast cancer cell line MDA-MB-231
33. Localization of gold in biological tissue. A photochemical method for light and electronmicroscopy
34. Thin cryosections and immunogold-silver staining
35. Tetrazolium-based assays for cellular viability: A critical examination of selected parameters affecting formazan production
36. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles
37. A genetic model for colorectal tumorgenesis
38. The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor
39. Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera
40. Tyrosine phosphorylation of selected secretory carrier membrane proteins, SCAMP1 and SCAMP3, and association with the EGF receptor
41. Clathrin, adaptors and eps15 in endosomes containing activated epidermal growth factor receptors
42. Negative regulation of epidermal growth factor signalling by selective proteolytic mechanisms in the endosome mediated by Cathepsin B
43. Epidermal growth factor ligand-independent, unregulated, cell-transformation potential of a naturally occurring human mutant EGFRvIII gene
44. Function of aberrant EGFR in malignant gliomas
45. Hepatocyte growth factor and transforming growth factor β stimulate both cell growth and migration of human gastric adenocarcinoma cells
46. Fibroblast growth factors modulate intestinal epithelial cell growth and migration
47. v-erbA oncogene induces invasiveness and anchorage-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor
48. Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro
49. Enhanced effect of epidermal growth factor on pulmonary metastasis and in vitro invasion of rat mammary carcinoma cells
50. Immunocytochemical localization of Shc and activated EGF receptor in early endosomes after EGF stimulation of HeLa cells
51. Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells
52. Modulation of tight junction structure and function by cytokines
53. Epidermal growth factor disrupts gap-junctional communication and induces phosphorylation of connexin43 on serine
54. Cyclic changes in the organization of cell adhesions and the associated cytoskeleton, induced by stimulation of tyrosine phosphorylation in bovine aortic endothelial cells
55. Cell-cell adhesion-mediated tyrosine phosphorylation of nectin-2-delta, an immunoglobulin-like cell adhesion molecule at adherence junctions
56. Tight junctions in the rat parotid gland
57. Gap junction intercellular communication in gliomas is inversely related to cell motility